Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol for Endothelial Progenitor Cells and Angiogenesis in PAOD
NCT01952756Phase 4Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- Jan 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in peripheral artery disease (PAD) comparing Cilostazol with Dummy Placebo (2 arms). Primary endpoint: Circulating Endothelial Progenitor Cells Number at 3 months. Started Jan 2012; status: completed.
02
Drugs
cilostazol
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT01952756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01952756.